Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Carmen Pastoriza"'
Autor:
Juan-Manuel Sancho, Ana Marín-Niebla, Silvia Fernández, Francisco-Javier Capote, Carolina Cañigral, Carlos Grande, Eva Donato, Izaskun Zeberio, Jose-Manuel Puerta, Alfredo Rivas, Elena Pérez-Ceballos, Ana Vale, Alejandro Martín García-Sancho, Antonio Salar, Eva González-Barca, Anabel Teruel, Carmen Pastoriza, Diego Conde-Royo, Joaquín Sánchez-García, Cristina Barrenetxea, Reyes Arranz, José-Ángel Hernández-Rivas, María-José Ramírez, Aroa Jiménez, Eva Rubio-Azpeitia
Publikováno v:
INTERNATIONAL JOURNAL OF HEMATOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
International Journal of Hematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-FISABIO. Repositorio Institucional de Producción Científica
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
International Journal of Hematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-FISABIO. Repositorio Institucional de Producción Científica
This retrospective study evaluated 66 patients diagnosed with relapsed and/or refractory mantle cell lymphoma (R/R MCL) treated with ibrutinib in Spain in routine clinical practice. At diagnosis, patients had a median age of 64.5 years, 63.6% present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33fbc67fbf5b2c7eef5c8a06b0493fb6
https://doi.org/10.1007/s12185-022-03367-z
https://doi.org/10.1007/s12185-022-03367-z
Autor:
Juan-Manuel Sancho, Jose Angel Hernandez Rivas, Carlos Grande, Alejandro Martín, Carmen Pastoriza, Cristina Barrenetxea, Joaquín Sánchez, Anabel Teruel, Cristina Loriente, Eva Gonzalez Barca, A. I. Marín, Francisco Javier Capote, Diego Conde Royo, Carolina Cañigral, Josefa Ramírez, Izaskun Zeberio, Aroa Jiménez, Jose Manuel Puerta, Silvia Fernández, Elena Pérez Ceballos, Antonio Salar, Ana Vale, Reyes Arranz, Eva Donato, Alfredo Rivas
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S258-S259
Context: Ibrutinib is a first-in-class oral inhibitor of Bruton's tyrosine kinase, has been established as a standard-of-care (SOC) treatment for R/R MCL. The clinical benefits with ibrutinib has been demonstrated in multiple trials and real-world st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aacfd397a181c68c17361b055d6e64fb
https://doi.org/10.1016/s2152-2650(20)30860-0
https://doi.org/10.1016/s2152-2650(20)30860-0
Autor:
Isabel Caparrós, Gonzalo Caballero, Jose Angel Hernandez-Rivas, Miguel A. Sanz, Inmaculada Soto Ortega, Fernando Fernández-Fuertes, Luis Javier garcia Frade, Blanca Sanchez-Gonzalez, Isabel Regalado, Silvia Bernat, Pável E Olivera, Tomás José González-López, Isidro Jarque, Carmen Pastoriza, Maria Cristina Pascual Izquierdo, María Paz Martínez-Badas, Gloria Perez Segura, Daniel Martínez-Carballeira
Publikováno v:
Blood. 134:2352-2352
Background: Successful discontinuation of eltrombopag in certain immune thrombocytopenia (ITP) patients after complete response has already been demonstrated. However, the frequency of this phenomenon and type of candidate patients are still matter o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::273d084cb6ad094051e3df0fcb422344
https://doi.org/10.1182/blood-2019-129274
https://doi.org/10.1182/blood-2019-129274